JP2006513184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513184A5 JP2006513184A5 JP2004560867A JP2004560867A JP2006513184A5 JP 2006513184 A5 JP2006513184 A5 JP 2006513184A5 JP 2004560867 A JP2004560867 A JP 2004560867A JP 2004560867 A JP2004560867 A JP 2004560867A JP 2006513184 A5 JP2006513184 A5 JP 2006513184A5
- Authority
- JP
- Japan
- Prior art keywords
- buprenorphine
- dosage form
- administration
- patient
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims 30
- 229960001736 buprenorphine Drugs 0.000 claims 30
- 239000002552 dosage form Substances 0.000 claims 19
- 238000000034 method Methods 0.000 claims 9
- 239000006211 transdermal dosage form Substances 0.000 claims 7
- 208000000094 Chronic Pain Diseases 0.000 claims 3
- 208000002193 Pain Diseases 0.000 claims 3
- 206010019233 Headaches Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- 230000002411 adverse Effects 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 230000008673 vomiting Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43342302P | 2002-12-13 | 2002-12-13 | |
| US60/433,423 | 2002-12-13 | ||
| PCT/US2003/039792 WO2004054553A1 (en) | 2002-12-13 | 2003-12-15 | Transdermal buprenorphine dosage regimen for analgesia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010182231A Division JP2010285457A (ja) | 2002-12-13 | 2010-08-17 | 鎮痛のためのブプレノルフィン経皮投与計画 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006513184A JP2006513184A (ja) | 2006-04-20 |
| JP2006513184A5 true JP2006513184A5 (https=) | 2006-12-14 |
| JP5054893B2 JP5054893B2 (ja) | 2012-10-24 |
Family
ID=32595187
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004560867A Expired - Fee Related JP5054893B2 (ja) | 2002-12-13 | 2003-12-15 | 鎮痛のためのブプレノルフィン経皮投与計画 |
| JP2010182231A Withdrawn JP2010285457A (ja) | 2002-12-13 | 2010-08-17 | 鎮痛のためのブプレノルフィン経皮投与計画 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010182231A Withdrawn JP2010285457A (ja) | 2002-12-13 | 2010-08-17 | 鎮痛のためのブプレノルフィン経皮投与計画 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7270830B2 (https=) |
| EP (1) | EP1572167B1 (https=) |
| JP (2) | JP5054893B2 (https=) |
| AT (1) | ATE400258T1 (https=) |
| AU (2) | AU2003297073A1 (https=) |
| CA (1) | CA2510223C (https=) |
| CY (1) | CY1108384T1 (https=) |
| DE (1) | DE60322102D1 (https=) |
| DK (1) | DK1572167T3 (https=) |
| ES (1) | ES2310262T3 (https=) |
| IL (1) | IL169056A (https=) |
| MX (1) | MXPA05006334A (https=) |
| NZ (1) | NZ539936A (https=) |
| PT (1) | PT1572167E (https=) |
| SI (1) | SI1572167T1 (https=) |
| WO (1) | WO2004054553A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| CA2487577C (en) * | 2002-05-31 | 2014-11-18 | Titan Pharmaceuticals, Inc. | Implantable polymeric device for sustained release of buprenorphine |
| AU2003297073A1 (en) * | 2002-12-13 | 2004-07-09 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| SI1610791T1 (sl) * | 2003-03-31 | 2011-05-31 | Titan Pharmaceuticals Inc | Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista |
| US8790689B2 (en) * | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
| KR101159828B1 (ko) * | 2003-04-30 | 2012-07-04 | 퍼듀 퍼머 엘피 | 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형 |
| DK1638492T3 (da) * | 2003-07-25 | 2008-05-13 | Euro Celtique Sa | Præoperativ behandling af postoperativ smerte |
| SI1646328T1 (sl) * | 2003-07-25 | 2008-02-29 | Euro Celtique Sa | Zdravljenje pri odvajanju od odvisnosti |
| US20060281775A1 (en) * | 2005-06-14 | 2006-12-14 | Applied Pharmacy Services, Inc. | Two-component pharmaceutical composition for the treatment of pain |
| BRPI0619806A2 (pt) * | 2005-12-13 | 2011-10-18 | Biodelivery Sciences Int Inc | dispositivo para fornecimento de fármacos transmucosal resistente ao abuso |
| RU2504377C2 (ru) | 2006-07-21 | 2014-01-20 | БайоДеливери Сайенсиз Интэнэшнл, Инк. | Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли |
| DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| EP1985292A1 (en) * | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| EP2262367A4 (en) * | 2008-03-08 | 2011-04-20 | Theraquest Biosciences Inc | PHARMACEUTICAL ORAL COMPOSITIONS OF BUPRENORPHINE AND METHOD FOR THEIR USE |
| WO2010047681A1 (en) * | 2008-10-24 | 2010-04-29 | Bridge Pharma, Inc. | Treating xerophthalmia with norketotifen |
| WO2010059894A1 (en) * | 2008-11-21 | 2010-05-27 | Bridge Pharma, Inc. | Ocular formulations of norketotifen |
| MX352959B (es) | 2011-08-18 | 2017-12-15 | Biodelivery Sciences Int Inc | Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina. |
| TW201338813A (zh) * | 2011-12-12 | 2013-10-01 | 洛曼治療系統股份有限公司 | 經皮遞送系統 |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| AU2013205080B2 (en) * | 2012-12-12 | 2016-07-07 | Lts Lohmann Therapie-Systeme Ag | Transdermal Delivery System |
| WO2014195352A1 (en) | 2013-06-04 | 2014-12-11 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system |
| JP7373904B2 (ja) * | 2016-02-29 | 2023-11-06 | パーク・セラピューティクス・インコーポレイテッド | セブラノパドールの滴定 |
| JP2022512230A (ja) * | 2018-12-14 | 2022-02-02 | ペア セラピューティクス インコーポレイテッド | ブプレノルフィン含有製品の誘導を最適化するためのデジタル治療構成要素 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA856002B (en) * | 1984-08-10 | 1987-04-29 | Du Pont | Transdermal delivery of opioids |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| EP0484543B1 (en) * | 1990-04-24 | 1995-12-13 | Teijin Limited | Plaster |
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| US5149538A (en) * | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
| JP2886021B2 (ja) * | 1993-03-19 | 1999-04-26 | 帝三製薬株式会社 | 安定な貼付剤 |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| JP2837337B2 (ja) * | 1993-08-10 | 1998-12-16 | 帝三製薬株式会社 | 貼付剤 |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| JP3662388B2 (ja) * | 1997-05-30 | 2005-06-22 | 日東電工株式会社 | 経皮吸収製剤及びその製造方法 |
| WO2003079945A1 (en) * | 2002-03-20 | 2003-10-02 | Euro-Celtique S.A. | Method of administering buprenorphine to treat depression |
| AU2003297073A1 (en) * | 2002-12-13 | 2004-07-09 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| WO2004103317A2 (en) * | 2003-05-15 | 2004-12-02 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for treatment of diarrhea |
| SI1646328T1 (sl) | 2003-07-25 | 2008-02-29 | Euro Celtique Sa | Zdravljenje pri odvajanju od odvisnosti |
-
2003
- 2003-12-15 AU AU2003297073A patent/AU2003297073A1/en not_active Abandoned
- 2003-12-15 US US10/736,043 patent/US7270830B2/en not_active Expired - Lifetime
- 2003-12-15 CA CA2510223A patent/CA2510223C/en not_active Expired - Fee Related
- 2003-12-15 ES ES03813444T patent/ES2310262T3/es not_active Expired - Lifetime
- 2003-12-15 AT AT03813444T patent/ATE400258T1/de active
- 2003-12-15 MX MXPA05006334A patent/MXPA05006334A/es active IP Right Grant
- 2003-12-15 JP JP2004560867A patent/JP5054893B2/ja not_active Expired - Fee Related
- 2003-12-15 NZ NZ539936A patent/NZ539936A/en not_active IP Right Cessation
- 2003-12-15 DE DE60322102T patent/DE60322102D1/de not_active Expired - Lifetime
- 2003-12-15 PT PT03813444T patent/PT1572167E/pt unknown
- 2003-12-15 DK DK03813444T patent/DK1572167T3/da active
- 2003-12-15 EP EP03813444A patent/EP1572167B1/en not_active Expired - Lifetime
- 2003-12-15 WO PCT/US2003/039792 patent/WO2004054553A1/en not_active Ceased
- 2003-12-15 SI SI200331365T patent/SI1572167T1/sl unknown
-
2005
- 2005-06-07 IL IL169056A patent/IL169056A/en active IP Right Grant
-
2008
- 2008-09-30 CY CY20081101079T patent/CY1108384T1/el unknown
-
2010
- 2010-04-14 AU AU2010201479A patent/AU2010201479B2/en not_active Ceased
- 2010-08-17 JP JP2010182231A patent/JP2010285457A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006513184A5 (https=) | ||
| JP2007515469A5 (https=) | ||
| JP2018507243A5 (https=) | ||
| NO944565D0 (no) | Preparat med regulert frigjörelse som inneholder et morfinsalt | |
| JP2009544619A5 (https=) | ||
| JP2002532392A5 (https=) | ||
| JP2009536147A5 (https=) | ||
| JP2009501801A5 (https=) | ||
| WO2004045593A3 (en) | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy | |
| JP2006516571A5 (https=) | ||
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| JP2012502103A5 (https=) | ||
| WO2005011579A3 (en) | Treatment of dependence withdrawal | |
| JP2009517411A5 (https=) | ||
| JP2006514681A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2011500589A5 (https=) | ||
| JP2002540148A5 (https=) | ||
| CA2563058A1 (en) | Supportive treatment of liver disease | |
| RU99119233A (ru) | Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени | |
| KR101267771B1 (ko) | 약제 조합을 이용한 치료 방법 및 이에 적합한 약제 조합 | |
| JP2021535163A5 (https=) | ||
| ES2184561A1 (es) | Forma farmaceutica solida de administracion oral dispersable en agua para el tratamiento de la tuberculosis conteniendo refampicina, isoniazida, pirazinamida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica. | |
| WO2007079195A3 (en) | Gastric retentive gabapentin dosage forms and methods for using same | |
| JP2006508994A5 (https=) |